SYNCOM FORMU (I) LTD (SYNCOMF) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]
Syncom Formu (i) Ltd
SYNCOMF
Market Cap₹1,231Cr.
Current Price₹13.1
High / Low₹19.1/10.2
Stock P/E16.2
Book Value₹4.39
Dividend Yield0.00%
ROCE26.8%
ROE20.2%
Face Value₹1.00
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 16:48:36